Overview
Background
Adam G. Stewart, BBiomedSci, MBBS (Hons), MPHTM, FRACP, FRCPA
Dr Adam Stewart is an Infectious Diseases Physician, Clinical Microbiologist and Physician-Scientist.
His research interests include clinical trials, new antimicrobials, diagnostics for infectious diseases, and infections involving transplant recipients and other immunocompromised patients.
Availability
- Dr Adam Stewart is:
- Available for supervision
- Media expert
Qualifications
- Bachelor of Biomedical Science, Griffith University
- Bachelor of Medicine and Surgery and Medical Science, Griffith University
- Masters (Coursework) of Public Health and Tropical Medicine, James Cook University
Research interests
-
New Antimicrobials
Pre-clinical and clinical research evaluating the efficacy of new antibacterial, antifungal and antiviral agents
-
Clinical Trials in Infectious Diseases
Randomised controlled trials to identify better treatment options for the management of infectious diseases
-
Diagnostics in Infectious Diseases
Evaluating the clinical utility of novel diagnostic platforms with regards to predicting risk of infection, pathogen identification and antimicrobial resistance testing
-
Infectious Complications in Transplant Recipients
Improving surveillance, detection and management of infectious diseases in solid organ and haematopoietic stem cell transplant recipients
Works
Search Professor Adam Stewart’s works on UQ eSpace
2021
Journal Article
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., or Serratia marcescens: a pilot multi-center randomized controlled trial (MERINO-2)
Stewart, Adam G., Paterson, David L., Young, Barnaby, Lye, David C, Davis, Joshua S., Schneider, Kellie, Yilmaz, Mesut, Dinleyici, Rumeysa, Runnegar, Naomi, Henderson, Andrew, Archuleta, Sophia, Kalimuddin, Shirin, Forde, Brian M., Chatfield, Mark D., Bauer, Michelle J., Lipman, Jeffrey, Harris-Brown, Tiffany, Harris, Patrick N. A. and for the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2021). Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., or Serratia marcescens: a pilot multi-center randomized controlled trial (MERINO-2). Open Forum Infectious Diseases, 8 (8) ofab387, ofab387. doi: 10.1093/ofid/ofab387
2021
Journal Article
Prolonged granulocyte transfusions sourced from buffy coats used to treat Aspergillus spp. infection in chronic granulomatous disease
Stewart, Adam G., Baidya, Shoma, Daly, James and Scott, Ashleigh P. (2021). Prolonged granulocyte transfusions sourced from buffy coats used to treat Aspergillus spp. infection in chronic granulomatous disease. Pathology, 54 (3), 358-361. doi: 10.1016/j.pathol.2021.05.098
2021
Journal Article
In vitro activity of Cefotetan against ESBL-producing Escherichia coli and Klebsiella pneumoniae bloodstream isolates from the MERINO Trial
Stewart, Adam G., Cottrell, Kyra, Henderson, Andrew, Vemuri, Kanthi, Bauer, Michelle J., Paterson, David L. and Harris, Patrick N. A. (2021). In vitro activity of Cefotetan against ESBL-producing Escherichia coli and Klebsiella pneumoniae bloodstream isolates from the MERINO Trial. Microbiology Spectrum, 9 (1) e00226-21, 1-6. doi: 10.1128/spectrum.00226-21
2021
Journal Article
New microbiological techniques for the diagnosis of bacterial infections and sepsis in ICU including point of care
Peri, Anna Maria, Stewart, Adam, Hume, Anna, Irwin, Adam and Harris, Patrick N A (2021). New microbiological techniques for the diagnosis of bacterial infections and sepsis in ICU including point of care. Current Infectious Disease Reports, 23 (8) 12, 12. doi: 10.1007/s11908-021-00755-0
2021
Journal Article
Completing the picture - capturing the resistome in antibiotic clinical trials
Stewart, Adam G., Satlin, Michael J., Schlebusch, Sanmarié, Isler, Burcu, Forde, Brian M., Paterson, David L. and Harris, Patrick N. A. (2021). Completing the picture - capturing the resistome in antibiotic clinical trials. Clinical Infectious Diseases, 72 (12), e1122-e1129. doi: 10.1093/cid/ciaa1877
2021
Journal Article
Listeria monocytogenes brain abscess as a late complication of allogeneic haemopoietic stem cell transplantation
Chung, Joseph, McCarthy, Kate L., Redmond, Andrew, Butler, Jason, Scott, Ashleigh P. and Stewart, Adam G. (2021). Listeria monocytogenes brain abscess as a late complication of allogeneic haemopoietic stem cell transplantation. Internal Medicine Journal, 51 (6), 1005-1006. doi: 10.1111/imj.15356
2021
Journal Article
Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia
Stewart, A. G., Price, E. P., Schabacker, K., Birikmen, M., Harris, P. N. A., Choong, K., Subedi, S. and Sarovich, D. S. (2021). Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia. Antimicrobial Agents and Chemotherapy, 65 (6) e00130-21, 1-13. doi: 10.1128/AAC.00130-21
2021
Journal Article
Just as good but better tolerated: posaconazole as first-line therapy for invasive aspergillosis
Stewart, Adam G. and Lane, Steven (2021). Just as good but better tolerated: posaconazole as first-line therapy for invasive aspergillosis. The Hematologist, 18 (3).
2021
Journal Article
How urgent is the need for new antifungals?
Stewart, Adam G. and Paterson, David L. (2021). How urgent is the need for new antifungals?. Expert Opinion on Pharmacotherapy, 22 (14), 1-14. doi: 10.1080/14656566.2021.1935868
2021
Journal Article
Infectious complications of CAR T-cell therapy: a clinical update
Stewart, Adam G. and Henden, Andrea S. (2021). Infectious complications of CAR T-cell therapy: a clinical update. Therapeutic Advances in Infectious Disease, 8 204993612110367, 1-11. doi: 10.1177/20499361211036773
2020
Journal Article
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa
Isler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. The Journal of Antimicrobial Chemotherapy, 76 (3), 550-560. doi: 10.1093/jac/dkaa511
2020
Journal Article
Achromobacter infections and treatment options
Isler, Burcu, Kidd, Timothy J., Stewart, Adam G., Harris, Patrick and Paterson, David L. (2020). Achromobacter infections and treatment options. Antimicrobial Agents and Chemotherapy, 64 (11) e01025, 1-16. doi: 10.1128/aac.01025-20
2020
Journal Article
Is ceftazidime/avibactam an option for serious infections due to ESBL and AmpC producing Enterobacterales?: a systematic review and meta-analysis
Isler, Burcu, Ezure, Yukiko, García-Fogeda Romero, Jose Luis, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). Is ceftazidime/avibactam an option for serious infections due to ESBL and AmpC producing Enterobacterales?: a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy, 65 (1) e01052-20. doi: 10.1128/AAC.01052-20
2020
Journal Article
Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in Australia
Stewart, Adam G., Burnard, Delaney, Sowden, David and McMillan, David (2020). Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in Australia. Pathology, 52 (6), 694-699. doi: 10.1016/j.pathol.2020.06.006
2020
Journal Article
Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections
Stewart, Adam G., Harris, Patrick N. A., Chatfield, Mark, Evans, Scott R., van Duin, David and Paterson, David L. (2020). Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections. Clinical Infectious Diseases, 71 (2), 433-439. doi: 10.1093/cid/ciz1132
2020
Journal Article
Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections
Stewart, Adam G., Harris, Patrick N. A., Henderson, Andrew, Schembri, Mark A. and Paterson, David L. (2020). Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. Journal of Antimicrobial Chemotherapy, 75 (9), 2384-2393. doi: 10.1093/jac/dkaa183
2020
Journal Article
New treatment options for multiresistant gram negatives
Paterson, David L., Isler, Burcu and Stewart, Adam (2020). New treatment options for multiresistant gram negatives. Current Opinion in Infectious Diseases, 33 (2), 214-223. doi: 10.1097/QCO.0000000000000627
2020
Journal Article
Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection
McNamara, John F., Avent, Minyon, Stewart, Adam, Kwan, Christopher and Paterson, David L. (2020). Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection. Infection, Disease and Health, 25 (3), 151-157. doi: 10.1016/j.idh.2020.01.003
2020
Conference Publication
Molecular epidemiology and hospital spread of ceftriaxone non-susceptible enterobacterales in the Sunshine Coast region, Australia
Stewart, Adam, Sarovich, Derek, Price, Erin, Burnard, Delaney, Harris, Patrick, Choong, Keat and Subedi, Shradha (2020). Molecular epidemiology and hospital spread of ceftriaxone non-susceptible enterobacterales in the Sunshine Coast region, Australia. RACP Congress 2020: Balancing medical science with humanity, Online, May 2020. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/imj.4_14846
2020
Journal Article
Initiating tuberculosis treatment at end of life – Balancing patient and infection control interests
Stewart, Adam G. and Wright, Hugh (2020). Initiating tuberculosis treatment at end of life – Balancing patient and infection control interests. Infection, Disease and Health, 25 (4), 283-285. doi: 10.1016/j.idh.2020.05.009
Funding
Current funding
Past funding
Supervision
Availability
- Dr Adam Stewart is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
Contact Dr Adam Stewart directly for media enquiries about:
- clinical trial
- infectious diseases
- superbugs
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: